331 related articles for article (PubMed ID: 16838110)
1. The management of ductal carcinoma in situ of the breast: a screened population-based analysis.
Rakovitch E; Pignol JP; Chartier C; Hanna W; Kahn H; Wong J; Mai V; Paszat L
Breast Cancer Res Treat; 2007 Mar; 101(3):335-47. PubMed ID: 16838110
[TBL] [Abstract][Full Text] [Related]
2. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET
J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
[TBL] [Abstract][Full Text] [Related]
3. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
4. Results of 23,810 cases of ductal carcinoma-in-situ.
Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
[TBL] [Abstract][Full Text] [Related]
5. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
8. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
[TBL] [Abstract][Full Text] [Related]
10. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
11. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
12. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
13. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
14. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
17. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
Buchholz TA; Theriault RL; Niland JC; Hughes ME; Ottesen R; Edge SB; Bookman MA; Weeks JC
J Clin Oncol; 2006 Jan; 24(3):361-9. PubMed ID: 16421417
[TBL] [Abstract][Full Text] [Related]
18. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
[TBL] [Abstract][Full Text] [Related]
19. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
Joslyn SA
Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
